IceCure Medical Ltd
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -1.46 | $907,000 | -$4M |
| 2026 Q1 | -1.74 | $911,000 | -$4M |
| 2025 Q4 | -1.75 | $1M | -$5M |
| 2025 Q3 | -1.77 | $850,000 | -$3M |
| 2025 Q2 | -1.72 | $525,000 | -$3M |
| 2025 Q1 | -1.87 | $725,000 | -$4M |
| 2024 Q4 |
| -2.42 |
| $875,000 |
| -$4M |
| 2024 Q3 | -2.38 | $662,000 | -$3M |